Companies: 49,246 Total Market Cap: 132441797263938.02

GH Research PLC

NASDAQ: GHRS

Healthcare Biotechnology

Rank #10852

Market Cap 762.95 M

Volume 212,632

Price 12.30

Change (%) 5.13%

Country or region

Ireland

GH Research PLC's latest marketcap:

762.95 M

As of 05/20/2025, GH Research PLC's market capitalization has reached $762.95 M. According to our data, GH Research PLC is the 10852th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	762.95 M
Revenue (ttm)	0
Net Income (ttm)	-42,107,000
Shares Out	62.03 M
EPS (ttm)	-0.79
Forward PE	0.00
Ex-Dividend Date	n/a
Earnings Date	05/08/2025

Market Cap Chart

Data Updated: 05/20/2025

GH Research PLC's yearly market capitalization.

GH Research PLC has seen its market value drop from $1.21 B to $762.95 M since 2021, representing a total decrease of 37.14% and an annual compound decline rate (CAGR) of 12.81%.

Date	Market Cap	Change (%)
05/20/2025	$762.95 M	76.79%
12/31/2024	$364.20 M	20.71%
12/29/2023	$301.72 M	-40.33%
12/30/2022	$505.64 M	-58.34%
12/31/2021	$1.21 B

Company Profile

About GH Research PLC

GH Research PLC, along with its subsidiary, is a clinical-stage biopharmaceutical company focused on developing innovative treatments for depression and related disorders in the United States.

Key Product Candidates

GH001 – An inhalable mebufotenin product candidate currently in:
- Phase 2b clinical trial for treatment-resistant depression.
- Phase 2a clinical trials for bipolar II disorder with major depressive episodes and postpartum depression in female patients.
GH002 – An intravenous mebufotenin product candidate in Phase 1 clinical trials for psychiatric and neurological disorders, targeting healthy volunteers.

Company Background

Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.

Frequently Asked Questions

As of 05/20/2025, GH Research PLC (including the parent company, if applicable) has an estimated market capitalization of $762.95 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

GH Research PLC global market capitalization ranking is approximately 10852 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	Ireland
Founded	2018
IPO Date	06/25/2021
Employees	50
CEO	Velichka Valcheva
Sector	Healthcare
Industry	Biotechnology
Address	Joshua Dawson House, Dawson Street Dublin, D02 RY95 Ireland
Website	https://www.ghres.com